Among which, CCDC22, RAB7A, ATP6V1A, and ATP6AP1 expressions were significantly associated with the poor overall survival of LAML, suggesting a possibility that patients with hematological cancer (LAML) after SARS-CoV-2 infection may have a poor prognosis, and might support conclusions by Bernard et al. This evidence concerns the gene ATP6AP1 and hematopoietic and lymphoid cell neoplasm.